Literature DB >> 34921054

Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist.

Katherine L Hull1,2, Sherna F Adenwalla1,2, Peter Topham3, Matthew P Graham-Brown1.   

Abstract

Around 3 million people in the UK have chronic kidney disease and 20% of hospital admissions are complicated by acute kidney injury. Decline in kidney function is not a diagnosis; it is essential to identify and treat underlying causes of acute and chronic kidney disease to either achieve recovery or slow the decline of kidney function. Thorough clinical assessment and simple investigations help determine the category of kidney injury (pre-renal, intrinsic or post-renal) and inform the need for kidney biopsy, which can provide significant information in the evaluation of suspected intrinsic kidney disease, supporting diagnosis, guiding prognosis and management, and identifying disease relapse. The procedure is invasive and not without risk, which although small has the potential to be both organ- and life-threatening. This review outlines roles of kidney biopsy for the non-specialist, with focus of its role in patients with diabetes, lupus, myeloma and in the older patient. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  acute kidney injury; chronic kidney disease; haematuria; kidney biopsy; proteinuria

Mesh:

Year:  2021        PMID: 34921054      PMCID: PMC8813013          DOI: 10.7861/clinmed.2021-0472

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  45 in total

1.  Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis.

Authors:  Renato Alberto Sinico; Andrea Doria; Gabriella Moroni; Paolo Gilles Vercelloni; Silvana Quaglini; Mariele Gatto; Davide Gianfreda; Lucia Sacchi; Francesca Raffiotta; Margherita Zen; Gloria Costantini; Maria Letizia Urban; Federico Pieruzzi; Piergiorgio Messa; Augusto Vaglio
Journal:  Ann Rheum Dis       Date:  2018-05-05       Impact factor: 19.103

2.  Risk Factors Associated with Major Complications after Ultrasound-Guided Percutaneous Renal Biopsy of Native Kidneys.

Authors:  Beatriz Pombas; Eva Rodríguez; Juan Sánchez; Aleksandar Radosevic; Javier Gimeno; Marcos Busto; Clara Barrios; Laia Sans; Julio Pascual; María José Soler
Journal:  Kidney Blood Press Res       Date:  2019-12-10       Impact factor: 2.687

Review 3.  International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Authors:  S Vincent Rajkumar; Meletios A Dimopoulos; Antonio Palumbo; Joan Blade; Giampaolo Merlini; María-Victoria Mateos; Shaji Kumar; Jens Hillengass; Efstathios Kastritis; Paul Richardson; Ola Landgren; Bruno Paiva; Angela Dispenzieri; Brendan Weiss; Xavier LeLeu; Sonja Zweegman; Sagar Lonial; Laura Rosinol; Elena Zamagni; Sundar Jagannath; Orhan Sezer; Sigurdur Y Kristinsson; Jo Caers; Saad Z Usmani; Juan José Lahuerta; Hans Erik Johnsen; Meral Beksac; Michele Cavo; Hartmut Goldschmidt; Evangelos Terpos; Robert A Kyle; Kenneth C Anderson; Brian G M Durie; Jesus F San Miguel
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

4.  Difference between orthostatic and march functional proteinuria by application of stress tolerance test and SDS-PAGE.

Authors:  P G Korneti; V B Tasic; L K Jovanoska; B K Korneti
Journal:  Clin Chim Acta       Date:  2000-07       Impact factor: 3.786

Review 5.  Dysproteinemia and the Kidney: Core Curriculum 2019.

Authors:  Jonathan J Hogan; Mariam Priya Alexander; Nelson Leung
Journal:  Am J Kidney Dis       Date:  2019-07-19       Impact factor: 8.860

6.  Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.

Authors:  Laure Ecotière; Antoine Thierry; Céline Debiais-Delpech; Sylvie Chevret; Vincent Javaugue; Estelle Desport; Simohamed Belmouaz; Nathalie Quellard; Sihem Kaaki; Jean Michel Goujon; Jean-Paul Fermand; Guy Touchard; Frank Bridoux
Journal:  Nephrol Dial Transplant       Date:  2015-08-19       Impact factor: 5.992

7.  International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment.

Authors:  Meletios A Dimopoulos; Pieter Sonneveld; Nelson Leung; Giampaolo Merlini; Heinz Ludwig; Efstathios Kastritis; Hartmut Goldschmidt; Douglas Joshua; Robert Z Orlowski; Raymond Powles; David H Vesole; Laurent Garderet; Hermann Einsele; Antonio Palumbo; Michele Cavo; Paul G Richardson; Philippe Moreau; Jesús San Miguel; S Vincent Rajkumar; Brian G M Durie; Evangelos Terpos
Journal:  J Clin Oncol       Date:  2016-03-14       Impact factor: 44.544

Review 8.  Lupus nephritis: When and how often to biopsy and what does it mean?

Authors:  Gabriella Moroni; Federica Depetri; Claudio Ponticelli
Journal:  J Autoimmun       Date:  2016-06-24       Impact factor: 7.094

9.  Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria.

Authors:  D O McGregor; K L Lynn; R R Bailey; R A Robson; J Gardner
Journal:  Clin Nephrol       Date:  1998-06       Impact factor: 0.975

Review 10.  The value of repeat biopsy in lupus nephritis flares.

Authors:  Javier Narváez; Milagros Ricse; Montserrat Gomà; Francesca Mitjavila; Xavier Fulladosa; Olga Capdevila; Joan Torras; Xavier Juanola; Ramón Pujol-Farriols; Joan Miquel Nolla
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

View more
  2 in total

1.  Do you need a weatherman to know which way the wind blows?

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2022-01       Impact factor: 2.659

2.  Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis.

Authors:  Yun-Ju Huang; Chiung-Hung Lin; Huang-Yu Yang; Shue-Fen Luo; Chang-Fu Kuo
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.